Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/95019
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDharmapatni, A.en
dc.contributor.authorCantley, M.en
dc.contributor.authorMarino, V.en
dc.contributor.authorPerilli, E.en
dc.contributor.authorCrotti, T.en
dc.contributor.authorSmith, M.en
dc.contributor.authorHaynes, D.en
dc.date.issued2015en
dc.identifier.citationMediators of Inflammation, 2015; 2015:564042-1-564042-10en
dc.identifier.issn0962-9351en
dc.identifier.issn1466-1861en
dc.identifier.urihttp://hdl.handle.net/2440/95019-
dc.descriptionResearch articleen
dc.description.abstractObjective. To investigate the effect of Embelin, an inhibitor of X-Linked Inhibitor of Apoptosis Protein (XIAP), on inflammation and bone erosion in a collagen antibody induced arthritis (CAIA) in mice. Methods. Four groups of mice (n = 6 per group) were allocated: CAIA untreated mice, CAIA treated with Prednisolone (10 mg/kg/day), CAIA treated with low dose Embelin (30 mg/kg/day), and CAIA treated with high dose Embelin (50 mg/kg/day). Joint inflammation was evaluated using clinical paw score and histological assessments. Bone erosion was assessed using micro-CT, tartrate resistant acid phosphatase (TRAP) staining, and serum carboxy-terminal collagen crosslinks (CTX-1) ELISA. Immunohistochemistry was used to detect XIAP protein. TUNEL was performed to identify apoptotic cells. Results. Low dose, but not high dose Embelin, suppressed inflammation as reflected by lower paw scores (P < 0.05) and lower histological scores for inflammation. Low dose Embelin reduced serum CTX-1 (P < 0.05) and demonstrated lower histological score and TRAP counting, and slightly higher bone volume as compared to CAIA untreated mice. XIAP expression was not reduced but TUNEL positive cells were more abundant in Embelin treated CAIA mice. Conclusion. Low dose Embelin suppressed inflammation and serum CTX-1 in CAIA mice, indicating a potential use for Embelin to treat pathological bone loss.en
dc.description.statementofresponsibilityAnak A. S. S. K. Dharmapatni, Melissa D. Cantley, Victor Marino, Egon Perilli, Tania N. Crotti, Malcolm D. Smith, and David R. Haynesen
dc.language.isoenen
dc.publisherHindawi Publishing Corporationen
dc.rights© 2015 Anak A. S. S. K. Dharmapatni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.subjectAnimals; Mice; Bone Resorption; Arthritis, Experimental; Inflammation; Benzoquinones; Acid Phosphatase; Isoenzymes; X-Linked Inhibitor of Apoptosis Protein; Tartrate-Resistant Acid Phosphataseen
dc.titleThe X-Linked Inhibitor of Apoptosis Protein inhibitor embelin suppresses inflammation and bone erosion in collagen antibody induced arthritis miceen
dc.typeJournal articleen
dc.identifier.rmid0030023875en
dc.identifier.doi10.1155/2015/564042en
dc.identifier.pubid109667-
pubs.library.collectionMedicine publicationsen
pubs.library.teamDS08en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidCantley, M. [0000-0002-7188-0928]en
dc.identifier.orcidCrotti, T. [0000-0002-5422-3758]en
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_95019.pdfPublished version6.27 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.